White background with no visible content or imagery.

Strategic Communications

The way a company communicates about its science shapes how that science is perceived, by clinicians, by patients, by investors and by regulators. Strategic communications in life sciences is not about spin or marketing language. It is about ensuring that the right messages reach the right audiences with the clarity and credibility they require.

At Niche, we help companies think carefully about what they are trying to communicate, to whom and why, before they begin.
Get In Touch
“As a medium cap business we make a balance between large scale projects and nimble execution. We value the quality, focus and dedication that external providers bring to our projects. That is exactly what we found with Niche. The quality of the work delivered by the Niche teams and their attitude to our projects have always been of the highest standard. Niche are proactive, eager to share their insights, provide timely guidance where necessary and generally augment our projects.”
Miklail Tsyferov
CEO
Petrovax, Russia

What We Do

We support life science companies at the intersection of scientific, regulatory and commercial communication. This is a space where strategic missteps can have real consequences, where a publication strategy misaligned with a regulatory submission or a press release that overstates the significance of clinical data can create problems that take considerable effort to resolve. 

Our work in this area draws on our broader experience in medical communications, publication planning and regulatory affairs. We understand how these activities connect and where inconsistency between them creates risk.

Mind map showing Medical Communication Services branching to five categories: Conference Abstracts, Clinical Trial Summaries, Product Monographs, Primary and Secondary Manuscripts, and Lay Summaries.

How We Work

Strategic communications work begins with an honest assessment of the scientific story a company has to tell, and the audiences that story needs to reach. We are direct about what the data supports and what it does not, because communications built on overstatement rarely achieve their intended purpose and frequently cause harm. 

We work with companies to develop communication frameworks that are consistent across all channels and audiences, and that can be adapted as the scientific programme evolves. Practical deliverables, from key message documents through to publication plans and stakeholder briefings, follow from that strategic foundation.

Scope Of Service 

  • Communication strategy development 
  • Key message and narrative development 
  • Publication strategy and planning 
  • Congress and symposium strategy 
  • Medical affairs communication support 
  • Stakeholder mapping and engagement planning 
  • Advisory board strategy 
  • Scientific platform documents 
  • Disease awareness programme support 
  • Integrated evidence generation and communication planning 
  • Data disclosure strategy 
  • Crisis and issue communications support
Download our services guide 
Frequently Asked Questions
A scientific platform document is a comprehensive, internally-used document that captures the totality of the scientific story for a product or therapeutic area. It integrates the evidence base, defines the key messages that the company wants to communicate, and provides a single reference point that ensures consistency across all external communications. It is particularly useful when multiple agencies, departments or vendors are producing communications materials for the same product.
The tension between scientific accuracy and commercial communication is real and should be taken seriously. We work with both scientific and commercial teams to establish what the data authentically supports, and to develop messaging that is both commercially useful and scientifically defensible. This typically requires a clear process for reviewing materials before they are published or presented, and a shared understanding of where the lines are.
Earlier than most companies do. The decisions made in early clinical development, about what endpoints to measure, how to position the product relative to existing treatments, and which patient populations to focus on, have significant implications for how the scientific story can be communicated later. Thinking strategically about communications from the outset allows those decisions to be made with a clearer understanding of their downstream consequences.

Case Histories

Get our latest news and publications

Sign up to our news letter

© 2025 Niche.org.uk     All rights reserved

HomePrivacy policy Corporate Social Responsibility
chevron-down